CMS specifies that only 28-day or 30-day supplies are covered per fill, and that switching between covered GLP-1 drugs triggers a new prior authorization
Your digestive tract contains millions of GLP-1 receptors, and flooding them with medication before adaptation occurs triggers a cascade of adverse responses including severe nausea, vomiting, and constipation that often force dose reductions anyway
Your healthcare provider will review your complete medical history, including previous weight loss attempts, current medications, and any contraindications to GIP/GLP-1 receptor agonist therapy
by the UK Medical Research Council (MR/N00065X/1), and J.R
Does the "black box warning" about thyroid cancer apply to you
[1, 2] G6PD deficiency, an X-linked recessive disorder, is the major cause of decreased G6PD activity